推荐产品
检测方案
≥98% (GC)
质量水平
形式
powder
颜色
white to off-white
溶解性
methanol: 50 mg/mL
创始人
Boehringer Ingelheim
储存温度
2-8°C
SMILES字符串
Cl[H].CC(N)COc1c(C)cccc1C
InChI
1S/C11H17NO.ClH/c1-8-5-4-6-9(2)11(8)13-7-10(3)12;/h4-6,10H,7,12H2,1-3H3;1H
InChI key
NFEIBWMZVIVJLQ-UHFFFAOYSA-N
基因信息
human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)
正在寻找类似产品? 访问 产品对比指南
一般描述
美西律是一种IB类抗心律失常药，是利多卡因的类似物。它的半衰期为10-12小时，在肝脏中代谢，通过还原、氧化或结合反应消除。
应用
盐酸美西律可作为钠离子通道阻滞剂用于：
- 中国仓鼠卵细胞
- 人胚胎肾 (HEK) 细胞，用于全细胞膜片钳研究
- 表达Nav1.7蛋白的HEK细胞的电生理研究
生化/生理作用
美西律是一种有效的钠离子通道阻滞药。它是一种抗心律失常药，在头疼和神经性疼痛中可作为辅助药物美西律用于治疗钠离子通道病的肌强直症状，并缩短心脏动作电位的去极化时程，但不会对心房不应期造成影响。它对钠通道的抑制作用可有效治疗钾加重性肌强直。
特点和优势
该化合物由 Boehringer Ingelheim 开发。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单，请单击此处。
警示用语：
Warning
危险声明
危险分类
Acute Tox. 4 Oral
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Arnold E Pfahnl et al.
Heart rhythm, 4(1), 46-53 (2007-01-03)
Brugada and long QT type 3 syndromes are linked to sodium channel mutations and clinically cause arrhythmias that lead to sudden death. We have identified a novel threonine-to-isoleucine missense mutation at position 353 (T353I) adjacent to the pore-lining region of
E L Logigian et al.
Neurology, 74(18), 1441-1448 (2010-05-05)
To determine if mexiletine is safe and effective in reducing myotonia in myotonic dystrophy type 1 (DM1). Myotonia is an early, prominent symptom in DM1 and contributes to decreased dexterity, gait instability, difficulty with speech/swallowing, and muscle pain. A few
J F Desaphy et al.
Neuromuscular disorders : NMD, 9(3), 182-189 (1999-06-26)
The sea anemone toxin ATX II impairs skeletal muscle sodium channel inactivation, mimicking the persistent inward current observed in patients suffering from sodium channel myotonia. Mexiletine has beneficial effects on myotonia. To verify the efficiency of the drug on persistent
Erythromelagia: a rare and hard-to-treat condition: a 9-year-old boy responsive to intravenous lidocaine and oral mexilitene.
Francisca Elgueta et al.
Pain medicine (Malden, Mass.), 14(2), 311-312 (2013-02-02)
Tomoyuki Suzuki et al.
Cardiovascular research, 98(1), 136-144 (2013-01-24)
Na(+) channel blockers are often used to treat atrial fibrillation (AF), but may sometimes cause ventricular contractile dysfunction. However, amiodarone, a multi-channel blocker with Na(+) channel block, causes less contractile dysfunction. In this study, we tested the hypothesis that Na(+)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门